Vaccines Europe pipeline review 2024
This report covers the period from August 2023 to August 2024, highlighting the latest developments within the vaccine industry and how these innovations are addressing existing and upcoming health threats.
News
Policy & Recommendations
Cardiovascular health: Council calls for more robust efforts to help prevent cardiovascular diseases
In conclusions recently approved, the Council puts forward a series of measures aimed at improving cardiovascular health in the EU, focusing specifically on prevention, early detection, treatment and rehabilitation.
For a Pivotal Vaccine: Trial, Error, and Two Young Lives
The new RSV vaccines are medical milestones. But what is owed to the families who unknowingly helped pave the way?
Health systems need to use the new tools to address RSV, a leading cause of baby hospitalisations
From being a largely unknown pathogen, RSV is now almost a household word. New solutions, such as long-acting monoclonal antibodies and maternal vaccination, both recently recommended by WHO, could dramatically alter the RSV landscape.
|
ESWI Airborne: Intervention Strategies of Acute Respiratory Virus Infections
Flu Vaccines: Advancements, Challenges, and Global Impact – Expert Insights on Vaccine Platforms and Immune Responses
In this phenomenal episode, three leading experts in the field of vaccinology and immunology dive into the science behind various vaccine platforms and immune responses
World Diabetes Day 2024: Influenza Diabetes Community campaign
IDC launched a social media campaign to highlight the impact of influenza on people living with diabetes and the crucial importance of influenza vaccine uptake for this risk group.
H5N1 Bird Flu continues to take its toll in the United States, also affecting British Columbia
Clade 2.3.4.4b of the highly pathogenic avian influenza (HPAI) virus causing outbreaks in wild and domestic birds around the world, continues to spread in dairy cows, poultry and other animals across the United States.
News
Policy & Recommendations
Health at Glance: Europe 2024
Developed by the OECD in cooperation with the European Commission, this report series assesses the EU's progress toward effective, accessible, and resilient health systems.
Nirsevimab Effectiveness Against Medically Attended Respiratory Syncytial Virus Illness and Hospitalization Among Alaska Native Children — Yukon-Kuskokwim Delta Region, Alaska, October 2023–June 2024
Respiratory syncytial virus (RSV) is a leading cause of hospitalization among young children. Historically, American Indian and Alaska Native (AI/AN) children have experienced high rates of RSV-associated hospitalization.
|
ESWI Airborne: Life as a scientist
Essential skills and career prospects for early career scientists
Together with Meral Akcay, Lucy Mosscrop and Marco Goeijenbier we’ll delve into their unique journeys, the challenges they face, and the advice they offer to those just starting out in science.
COVID-19 pandemic interventions reshaped the global dispersal of seasonal influenza viruses
Despite the availability of updated seasonal influenza vaccines and treatments, annual influenza epidemics continue to cause millions of hospitalizations and substantial burden on health care systems.